Blocking a key receptor may curb immunotherapy-related liver damage

Scientists at UT Health San Antonio, the academic health center of The University of Texas at San Antonio (UT San Antonio), have found a potential path to maintaining the cancer-fighting benefits of one type of immunotherapy while limiting harmful organ damage, providing new hope for this promising treatment.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup